These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29344777)

  • 1. Giant Cell Arteritis: Practical Pearls and Updates.
    Pradeep S; Smith JH
    Curr Pain Headache Rep; 2018 Jan; 22(1):2. PubMed ID: 29344777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab in Giant Cell Arteritis.
    Mariano VJ; Frishman WH
    Cardiol Rev; 2018; 26(6):321-330. PubMed ID: 29570475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab for the treatment of giant cell arteritis.
    Schirmer M; Muratore F; Salvarani C
    Expert Rev Clin Immunol; 2018 May; 14(5):339-349. PubMed ID: 29676602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of biologics in the treatment of giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Opin Biol Ther; 2019 Jan; 19(1):65-72. PubMed ID: 30513026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Giant Cell Arteritis.
    Guevara M; Kollipara CS
    Curr Rheumatol Rep; 2018 Apr; 20(5):25. PubMed ID: 29611005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab in the treatment of giant cell arteritis.
    Leuchten N; Aringer M
    Immunotherapy; 2018 Mar; 10(6):465-472. PubMed ID: 29504436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates in the Diagnosis and Management of Giant Cell Arteritis.
    Uppal S; Hadi M; Chhaya S
    Curr Neurol Neurosci Rep; 2019 Aug; 19(9):68. PubMed ID: 31396718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Headache Federation recommendations for neurologists managing giant cell arteritis.
    Mollan SP; Paemeleire K; Versijpt J; Luqmani R; Sinclair AJ
    J Headache Pain; 2020 Mar; 21(1):28. PubMed ID: 32183689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.
    Miyabe C; Miyabe Y; Strle K; Kim ND; Stone JH; Luster AD; Unizony S
    Ann Rheum Dis; 2017 May; 76(5):898-905. PubMed ID: 27927642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological treatments in giant cell arteritis & Takayasu arteritis.
    Samson M; Espígol-Frigolé G; Terrades-García N; Prieto-González S; Corbera-Bellalta M; Alba-Rovira R; Hernández-Rodríguez J; Audia S; Bonnotte B; Cid MC
    Eur J Intern Med; 2018 Apr; 50():12-19. PubMed ID: 29146018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on giant cell arteritis.
    Sammel AM; Fraser CL
    Curr Opin Ophthalmol; 2018 Nov; 29(6):520-527. PubMed ID: 30138144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
    Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R
    Semin Arthritis Rheum; 2019 Aug; 49(1):126-135. PubMed ID: 30655091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.
    Régent A; Redeker S; Deroux A; Kieffer P; Ly KH; Dougados M; Liozon E; Larroche C; Guillevin L; Bouillet L; Espitia O; Costedoat-Chalumeau N; Soubrier M; Brihaye B; Lifermann F; Lefevre G; Puéchal X; Mouthon L; Toussirot E;
    J Rheumatol; 2016 Aug; 43(8):1547-52. PubMed ID: 27182063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tongue necrosis secondary to giant cell arteritis, successfully treated with tocilizumab: a case report.
    Cho YM; El Khoury L; Paramo J; Horowitz DM; Li JY; Kello N
    BMC Musculoskelet Disord; 2023 May; 24(1):382. PubMed ID: 37189114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritis.
    Svasti-Salee CR; Mollan SP; Morgan AW; Quick V
    BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31586951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab in giant cell arteritis: an update for the clinician.
    Ford JA; Gewurz D; Gewurz-Singer O
    Curr Opin Rheumatol; 2023 May; 35(3):135-140. PubMed ID: 36912060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
    Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
    Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab for giant cell arteritis: an amazing result.
    Işık M; Kılıç L; Doğan İ; Calgüneri M
    Rheumatol Int; 2013 Nov; 33(11):2961-2. PubMed ID: 22965672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A severe cerebral infarction associated with giant cell arteritis, which developed during tocilizumab therapy and was successfully treated with intravenous cyclophosphamide.
    Suzuki K; Akiyama M; Ishigaki S; Kondo Y; Saito S; Kikuchi J; Hanaoka H; Kaneko Y
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):453-457. PubMed ID: 36715093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and biological efficacy of tocilizumab in giant cell arteritis: report of three patients and literature review].
    Kieffer P; Hinschberger O; Ciobanu E; Jaeger-Bizet F; Drabo A; Mostoufizadeh T; Martzolff L
    Rev Med Interne; 2014 Jan; 35(1):56-9. PubMed ID: 24075627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.